Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01149_DB01198_nanopub.RA60LZhakRSioPOCEftSne9_omU33iS6My_hjXfG495r8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01149_DB01198 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01149_DB01198 label "DDI between Nefazodone and Zopiclone - Nefazodone, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if nefazodone is initiated, discontinued or dose changed. [drugbank_resource:DB01149_DB01198]" assertion.
- drugbank_resource:DB01149_DB01198 identifier "drugbank_resource:DB01149_DB01198" assertion.
- drugbank_resource:DB01149_DB01198 title "DDI between Nefazodone and Zopiclone - Nefazodone, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if nefazodone is initiated, discontinued or dose changed." assertion.
- drugbank:DB01149 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01149_DB01198 assertion.
- drugbank:DB01198 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01149_DB01198 assertion.